{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "interpro:IPR003966",
      "entity_text" : "thrombin",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:60606",
      "entity_text" : "clopidogrel",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The finding that no difference is observed in factor IXa-AT, factor Xa-AT, and TAT complexes between the vorapaxar and placebo groups might be explained by the concomitant use of aspirin and clopidogrel, which already reduces platelet dependent thrombin generation to such an extent that the impact of adding vorapaxar is only small.",
  "reading_complete" : "2020-08-03T12:40:21Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:39:34Z",
  "trigger" : "reduces",
  "evidence" : [ "clopidogrel, which already reduces platelet-dependent thrombin" ],
  "pmc_id" : "6697509",
  "score" : 0
}